title: Efficacy of acyclovir against herpesvirus infection in Quaker parakeets.
abstract: We evaluated the efficacy of acyclovir against experimentally induced herpesvirus infection (Pacheco's parrot disease) in Quaker parakeets. Thirty-two of 40 birds were challenge-exposed with 0.1 ml of a suspension of herpesvirus (10(4) median cell culture infective doses [CCID50]) given IM. Treatment with acyclovir was started 24 hours later and was continued for 7 days. The birds were allotted to 5 groups of 8 birds each. There was a considerable difference in mortality between groups 1-5. Of 8 bird in each group, 6 died in group 1 (control), 1 died in group 2 (gavage), 3 died in group 3 (low dose, IM), 4 died in group 4 (high dose, IM), and none died in group 5 (contact controls). There was a significant (P = 0.023) difference in mortality between groups 1 and 2, thus the oral form of acyclovir administered by gavage was the most efficacious therapeutic regimen. Clinical signs and death occurred after discontinuation of acyclovir in groups 2 and 3, whereas the mean time of death for the control group was 6 days after challenge exposure. Herpesvirus was recovered by inoculation of chick embryo cell culture with pooled tissue suspensions from all birds that died. Histologic evidence of herpesvirus infection was found in most birds that died, with the control group having the most severe lesions. Surviving Quaker parakeets were transferred to cages with seronegative Quaker parakeets with no known exposure to herpesvirus. There have been no deaths attributable to herpesvirus infection in a period exceeding 2 years.
authors.affiliation: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville 32610-0126.
authors.forename: T M
authors.initials: TM
authors.lastname: Norton
authors.forename: J
authors.initials: J
authors.lastname: Gaskin
authors.forename: G V
authors.initials: GV
authors.lastname: Kollias
authors.forename: B
authors.initials: B
authors.lastname: Homer
authors.forename: C H
authors.initials: CH
authors.lastname: Clark
authors.forename: R
authors.initials: R
authors.lastname: Wilson
mesh_terms: D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D000284:Administration, Oral; D000818:Animals; D001715:Bird Diseases / Q000188:drug therapy*; D006566:Herpesviridae Infections / Q000188:drug therapy / Q000662:veterinary*; D010240:Parakeets
chemical_list: D000212:Acyclovir